Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 11, 2012, Pages 1415-1419

  Danielsson, K ^a   Ebrahimi, M ^a   Wahlin, Y B ^a   Nylander, K ^a   Boldrup, L ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; MICRORNA; MICRORNA 26B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOPSY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MALE; MICRODISSECTION; MOUTH LESION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AUTOIMMUNE DISEASES; BASE SEQUENCE; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DNA PRIMERS; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84867579374     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04306.x     Document Type: Article

References (38)

1. Axell T, Rundquist L,. Oral lichen planus - a demographic study. Community Dent Oral Epidemiol 1987; 15: 52-56.
2. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13: 350-365. (Pubitemid 36041624)
3. Ebrahimi M, Wahlin YB, Coates PJ, et al. Detection of antibodies against p63 and p73 isoforms in sera from patients diagnosed with oral lichen planus. J Oral Pathol Med 2007; 36: 93-98. (Pubitemid 46089310)
4. Pindborg JJ, Reichart PA, Smith CJ, et al. Histological Typing of Cancer and Precancer of the Oral Mucosa. World Health Organization International Histological Classification of Tumours. Springer, Berlin, 1997: 29-30.
5. Clevers H,. At the crossroads of inflammation and cancer. Cell 2004; 118: 671-674. (Pubitemid 39221727)
6. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-867. (Pubitemid 36019639)
7. Philip M, Rowley DA, Schreiber H,. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004; 14: 433-439. (Pubitemid 39360991)
8. Herschman HR,. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299: 125-140. (Pubitemid 26007741)
9. Subbaramaiah K, Telang N, Ramonetti JT, et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996; 56: 4424-4429. (Pubitemid 26330450)
10. Prescott SM, Fitzpatrick FA,. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 2000; 1470: M69-M78. (Pubitemid 30155608)
11. Rajakariar R, Yaqoob MM, Gilroy DW,. COX-2 in inflammation and resolution. Mol Interv 2006; 6: 199-207. (Pubitemid 44455202)
12. Herschman HR, Talley JJ, DuBois R,. Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. Mol Imaging Biol 2003; 5: 286-303. (Pubitemid 38100890)
13. Boldrup L, Coates PJ, Hedberg Y, et al. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers. Int J Oncol 2005; 27: 1661-1667.
14. Zhang L, Bertucci AM, Smith KA, et al. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus. Arthritis Rheum 2007; 56: 4132-4141. (Pubitemid 350262341)
15. Suzuki J, Ogawa M, Futamatsu H, et al. A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. J Mol Cell Cardiol 2006; 40: 688-695.
16. Myers LK, Kang AH, Postlethwaite AE, et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 2000; 43: 2687-2693. (Pubitemid 32001734)
17. Lysitsa S, Samson J, Gerber-Wicht C, et al. COX-2 expression in oral lichen planus. Dermatology 2008; 217: 150-155.
18. Neppelberg E, Johannessen AC,. DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus. Eur Arch Otorhinolaryngol 2007; 264: 1223-1230. (Pubitemid 350194843)
19. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Gainza-Cirauqui ML, et al. Overexpression of cyclooxygenase-2 as a biomarker in different subtypes of the oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: 738-743.
20. de Moraes E, Dar NA, de Moura Gallo CV, et al. Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: balancing life and death during inflammatory stress and carcinogenesis. Int J Cancer 2007; 121: 929-937. (Pubitemid 47101627)
21. Ji Y, He Y, Liu L, et al. MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells. FEBS Lett 2010; 584: 961-967.
22. Wu N, Zhao X, Liu M, et al. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS ONE 2010; 6: e16264.
23. Zhao Y, Srivastava D,. A developmental view of microRNA function. Trends Biochem Sci 2007; 32: 189-197. (Pubitemid 46603281)
24. Erson AE, Petty EM,. MicroRNAs in development and disease. Clin Genet 2008; 74: 296-306.
25. VanGuilder HD, Vrana KE, Freeman WM,. Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 2008; 44: 619-626. (Pubitemid 351656280)
26. van der Meij EH, van der Waal I,. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003; 32: 507-512.
27. Rentoft M, Hultin S, Coates PJ, et al. Tubulin alpha-6 chain is a stably expressed reference gene in archival samples of normal oral tissue and oral squamous cell carcinoma. Exp Ther Med 2010; 1: 419-423.
28. Lukac J, Brozovic S, Vucicevic-Boras V, et al. Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus. Croat Med J 2006; 47: 53-58. (Pubitemid 43326902)
29. Greenhough A, Smartt HJ, Moore AE, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009; 30: 377-386.
30. Shibata M, Kodani I, Osaki M, et al. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 2005; 41: 304-312. (Pubitemid 40311759)
31. Pakfetrat A, Javadzadeh-Bolouri A, Basir-Shabestari S, et al. Oral Lichen Planus: a retrospective study of 420 Iranian patients. Med Oral Patol Oral Cir Bucal 2009; 14: E315-E318.
32. Rodstrom PO, Jontell M, Mattsson U, et al. Cancer and oral lichen planus in a Swedish population. Oral Oncol 2004; 40: 131-138. (Pubitemid 38030355)
33. Bermejo-Fenoll A, Sanchez-Siles M, Lopez-Jornet P, et al. Premalignant nature of oral lichen planus. A retrospective study of 550 oral lichen planus patients from south-eastern Spain. Oral Oncol 2009; 45: e54-e56.
34. Carbone M, Arduino PG, Carrozzo M, et al. Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis 2009; 15: 235-243.
35. Ingafou M, Leao JC, Porter SR, et al. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis 2006; 12: 463-468. (Pubitemid 44252538)
36. Hsue SS, Wang WC, Chen CH, et al. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 2007; 36: 25-29.
37. Eisen D,. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-214. (Pubitemid 34118376)
38. Lo Muzio L, Mignogna MD, Favia G, et al. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 1998; 34: 239-246. (Pubitemid 28318247)